03 Aug 2021 --- GenScript Biotech Corporation is collaborating with Allozymes, a synthetic biology company that uses specific technologies to “unlock protein engineering potential.” In this partnership, GenScript will provide the mutant libraries construction to Allozymes for its downstream applications across various industries, including pharmaceuticals, cosmetics and F&B applications.
